These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 23456305)

  • 1. Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND.
    Gaskill PJ; Calderon TM; Coley JS; Berman JW
    J Neuroimmune Pharmacol; 2013 Jun; 8(3):621-42. PubMed ID: 23456305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Neuropathogenesis in the Presence of a Disrupted Dopamine System.
    Nickoloff-Bybel EA; Calderon TM; Gaskill PJ; Berman JW
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):729-742. PubMed ID: 32506353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse.
    Gaskill PJ; Calderon TM; Luers AJ; Eugenin EA; Javitch JA; Berman JW
    Am J Pathol; 2009 Sep; 175(3):1148-59. PubMed ID: 19661443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine Increases CD14
    Calderon TM; Williams DW; Lopez L; Eugenin EA; Cheney L; Gaskill PJ; Veenstra M; Anastos K; Morgello S; Berman JW
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):353-370. PubMed ID: 28133717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era.
    Chilunda V; Calderon TM; Martinez-Aguado P; Berman JW
    Brain Res; 2019 Dec; 1724():146426. PubMed ID: 31473221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effects of Opioids on HIV Neuropathogenesis.
    Murphy A; Barbaro J; Martínez-Aguado P; Chilunda V; Jaureguiberry-Bravo M; Berman JW
    Front Immunol; 2019; 10():2445. PubMed ID: 31681322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis.
    Coley JS; Calderon TM; Gaskill PJ; Eugenin EA; Berman JW
    PLoS One; 2015; 10(2):e0117450. PubMed ID: 25647501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.
    Williams DW; Veenstra M; Gaskill PJ; Morgello S; Calderon TM; Berman JW
    Curr HIV Res; 2014; 12(2):85-96. PubMed ID: 24862333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the immune system in HIV-associated neuroinflammation and neurocognitive implications.
    Hong S; Banks WA
    Brain Behav Immun; 2015 Mar; 45():1-12. PubMed ID: 25449672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine Levels Induced by Substance Abuse Alter Efficacy of Maraviroc and Expression of CCR5 Conformations on Myeloid Cells: Implications for NeuroHIV.
    Matt SM; Nickoloff-Bybel EA; Rong Y; Runner K; Johnson H; O'Connor MH; Haddad EK; Gaskill PJ
    Front Immunol; 2021; 12():663061. PubMed ID: 34093554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte/macrophages and their role in HIV neuropathogenesis.
    Burdo TH; Lackner A; Williams KC
    Immunol Rev; 2013 Jul; 254(1):102-13. PubMed ID: 23772617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.
    Purohit V; Rapaka R; Shurtleff D
    Mol Neurobiol; 2011 Aug; 44(1):102-10. PubMed ID: 21717292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.
    Williams KC; Hickey WF
    Annu Rev Neurosci; 2002; 25():537-62. PubMed ID: 12052920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Macrophage Dopamine Receptors in Mediating Cytokine Production: Implications for Neuroinflammation in the Context of HIV-Associated Neurocognitive Disorders.
    Nolan RA; Muir R; Runner K; Haddad EK; Gaskill PJ
    J Neuroimmune Pharmacol; 2019 Mar; 14(1):134-156. PubMed ID: 30519866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis and HIV neuropathogenesis.
    Espey MG
    Med Hypotheses; 1995 Jun; 44(6):536-8. PubMed ID: 7476602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte mobilization, activation markers, and unique macrophage populations in the brain: observations from SIV infected monkeys are informative with regard to pathogenic mechanisms of HIV infection in humans.
    Williams K; Burdo TH
    J Neuroimmune Pharmacol; 2012 Jun; 7(2):363-71. PubMed ID: 22167311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An SIV macaque model of SIV and HAND: the need for adjunctive therapies in HIV that target activated monocytes and macrophages.
    Mallard J; Williams K
    J Neurovirol; 2018 Apr; 24(2):213-219. PubMed ID: 29435829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine toxicity and its implications during HIV-1 infection.
    Silverstein PS; Shah A; Gupte R; Liu X; Piepho RW; Kumar S; Kumar A
    J Neurovirol; 2011 Oct; 17(5):401-15. PubMed ID: 21786077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD14+CD16+ monocyte transmigration across the blood-brain barrier is associated with HIV-NCI despite viral suppression.
    Veksler V; Leon-Rivera R; Fleysher L; Gonzalez J; Lopez JA; Rubin LH; Morgello S; Berman JW
    JCI Insight; 2024 Sep; 9(17):. PubMed ID: 39253970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An SIV/macaque model targeted to study HIV-associated neurocognitive disorders.
    Beck SE; Queen SE; Metcalf Pate KA; Mangus LM; Abreu CM; Gama L; Witwer KW; Adams RJ; Zink MC; Clements JE; Mankowski JL
    J Neurovirol; 2018 Apr; 24(2):204-212. PubMed ID: 28975505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.